Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma.
Pharmaceutics. 2023 Aug 14;15(8):2130. doi: 10.3390/pharmaceutics15082130.
Pharmaceutics. 2023.
PMID: 37631344
Free PMC article.
Review.
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways.
Moon H, Park H, Chae MJ, Choi HJ, Kim DY, Ro SW.
Moon H, et al.
BMC Cancer. 2022 Apr 19;22(1):423. doi: 10.1186/s12885-022-09516-1.
BMC Cancer. 2022.
PMID: 35439973
Free PMC article.
Item in Clipboard
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.
Park H, Park H, Baek J, Moon H, Ro SW.
Park H, et al.
Biology (Basel). 2022 Apr 12;11(4):585. doi: 10.3390/biology11040585.
Biology (Basel). 2022.
PMID: 35453784
Free PMC article.
Review.
Item in Clipboard
Cite
Cite